2023 annual financial data
Larimar Therapeutics 2023 Operating margin
Larimar Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -41,758,000 USD and net income was -36,949,000 USD.
Operating cash flow was -33,459,000 USD.
Get free Larimar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -41,758,000 USD
- Net income
- -36,949,000 USD
- Operating cash flow
- -33,459,000 USD